Medicaid Watch was a 2025 series featuring policy research, polling and news about the Medicaid financing debate. This series is no longer active. For the latest publications on Medicaid, please visit this page.

Filter

91 - 99 of 99 Results

  • Medicaid Enrollment & Spending Growth: FY 2024 & 2025

    Issue Brief

    This brief analyzes Medicaid enrollment and spending trends for FY 2024 and FY 2025, based on data provided by state Medicaid directors as part of the 24th annual survey of Medicaid directors.

  • Again, No Medicaid

    From Drew Altman

    In his latest column, KFF President and CEO Drew Altman explains why Medicaid, despite former President Donald Trump's silence on the topic, warrants greater attention given the potential for drastic changes or cuts to it should Republicans win control in the election.

  • Medicaid Waiver Priorities Under the Trump and Biden-Harris Administrations

    Issue Brief

    Section 1115 Medicaid demonstration waivers offer states an avenue to test new approaches in Medicaid that differ from what is required by federal statute, so long as the approach is likely to “promote the objectives of the Medicaid program.” As with broader Medicaid policy, the future landscape of Section 1115 waivers depends on the outcome of the November 2024 presidential election as a new administration could focus on different priorities, rescind existing guidance, or withdraw already-approved waivers. This waiver watch summarizes five key areas of difference in 1115 waiver policy and waiver approvals under the Trump and Biden-Harris administrations.

  • The Collision of Medicaid World Views

    From Drew Altman

    In his latest column, KFF President and CEO Drew Altman writes about the fundamentally different world views of the Medicaid program by Republicans and Democrats and how those ideological divides have affected policy proposals, sometimes despite the program's popularity and broad reach.

  • Is Medicaid Too Big to… Block Grant?

    From Drew Altman

    In his latest column, KFF President and CEO Drew Altman examines how the politics around the Medicaid program have changed as it has grown much larger and more popular, making it even tougher to block grant the program to cut federal Medicaid spending and hand it off to the states.

  • The Shifting Sands for State Medicaid Programs Lurking in Our Data

    From Drew Altman

    KFF President and CEO Drew Altman examines the coming squeeze on state budgets and state Medicaid programs, stemming from declining federal matching funds, weakening state revenues, and competing state priorities, and the challenges it poses for states seeking to strengthen their programs and try innovative new approaches.

  • How Do Medicaid/CHIP Children with Special Health Care Needs Differ from Those with Private Insurance?

    Issue Brief

    This issue brief compares the demographics, health status, access to care, and coverage affordability of Medicaid/CHIP children with special health care needs to those with private insurance and those who are uninsured. Medicaid plays a key role for children with special health care needs by making coverage affordable and covering services that private coverage typically does not. Consequently, legislative proposals that would cap and reduce federal Medicaid funding may pose a particular risk to children with special health care needs and their providers. A companion brief describes Medicaid’s role for children with special health care needs.

  • Medicaid’s Role for Children with Special Health Care Needs: A Look at Eligibility, Services, and Spending

    Issue Brief

    This issue brief describes the role that Medicaid plays for children with special health care needs. It explains common eligibility pathways, covered services, and program spending for these children. The Appendix includes 50-state data on the number of children with special health care needs covered by Medicaid/CHIP. A companion brief compares key characteristics of Medicaid/CHIP children with special health care needs to those covered by private insurance.